Clinical Trials on Intracellular Signaling Peptides and Proteins in New Zealand
Total 1088 results
-
BayerAmerican Thrombosis and Hemostasis NetworkTerminated
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Roswell Park Cancer InstituteCompletedPlasma Cell MyelomaUnited States
-
BayerCompletedHemophilia ABelgium, New Zealand, Netherlands, Greece, United Kingdom, Austria, United States, Italy, Romania, Bulgaria, Canada, Israel, Poland, Lithuania, Norway, Argentina, Spain
-
Memorial Sloan Kettering Cancer CenterRecruitingMultiple Myeloma | OsteoporosisUnited States
-
University of California, DavisTerminatedHemophilia A | Hemophilia A With InhibitorUnited States
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted
-
Memorial Sloan Kettering Cancer CenterRecruitingMultiple Myeloma | Refractory Multiple Myeloma | Relapse Multiple MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterJanssen PharmaceuticalsActive, not recruiting
-
BayerCompleted
-
GPCR Therapeutics, Inc.Recruiting
-
American Thrombosis and Hemostasis NetworkBayer; Shire; CSL Behring; Bioverativ Therapeutics Inc.Completed
-
Yale UniversityTerminatedAsymptomatic MyelomaUnited States
-
Merck Sharp & Dohme LLCActive, not recruitingPIK3CA-Related Overgrowth Spectrum (PROS)/Proteus Syndrome (PS)United States, Australia, Brazil, Italy, United Kingdom
-
Hackensack Meridian HealthSuspendedMultiple MyelomaUnited States
-
Travera IncMassachusetts General Hospital; Dana-Farber Cancer Institute; Weill Medical College... and other collaboratorsRecruitingMultiple Myeloma in RelapseUnited States
-
University of Medicine and Dentistry of New JerseyNational Cancer Institute (NCI)TerminatedLymphoma | Myelodysplastic Syndromes | Leukemia | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
Millennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States, Poland, Greece, Australia, Sweden
-
Hackensack Meridian HealthKaryopharm Therapeutics IncRecruitingMultiple MyelomaUnited States
-
Dana-Farber Cancer InstituteMemorial Sloan Kettering Cancer Center; Massachusetts General Hospital; Beth... and other collaboratorsCompleted
-
Incyte CorporationCompleted
-
Geron CorporationCompletedMultiple MyelomaUnited States
-
Biotest Pharmaceuticals CorporationBiotestCompletedMultiple MyelomaUnited States
-
Georgetown UniversityJanssen, LPRecruitingMonoclonal Gammopathy of Undetermined Significance | Peripheral NeuropathyUnited States
-
Canadian Myeloma Research GroupMerck Sharp & Dohme LLCWithdrawn
-
PfizerCompletedMultiple MyelomaCanada, United States
-
Seagen Inc.Genentech, Inc.CompletedMultiple MyelomaUnited States
-
Taiho Oncology, Inc.TerminatedMultiple Myeloma | NonHodgkin LymphomaUnited States
-
Genta IncorporatedCompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
NYU Langone HealthCompletedMultiple Myeloma | Osteoporosis | Disease of the MarrowUnited States
-
University of Maryland, BaltimoreNational Cancer Institute (NCI); University of Maryland Greenebaum Cancer CenterCompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
University of North Carolina, Chapel HillAmerican Cancer Society, Inc.CompletedLeukemia | Multiple Myeloma | Acute Leukemia | Psychological Distress | Acute Lymphocytic Leukemia | Hematological CancersUnited States
-
Biotest Pharmaceuticals CorporationBiotestCompletedMultiple MyelomaUnited States
-
New Mexico Cancer Care AllianceNovartisTerminatedMultiple Myeloma in RelapseUnited States
-
Bioverativ Therapeutics Inc.CompletedHemophilia AUnited States, Canada, Italy, Australia, Austria, Belgium, Brazil, France, Germany, Hong Kong, India, Ireland, Israel, Japan, Netherlands, New Zealand, Poland, South Africa, Spain, Sweden, Switzerland, United Kingdom
-
Omar AljitawiCompleted
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With InhibitorsUnited States
-
Stockton UniversityNova Southeastern UniversityCompletedCommon Variable Immunodeficiency | Hypergammaglobulinemia | Primary Immune Deficiency Disorder | Specific Antibody DeficiencyUnited States
-
Memorial Sloan Kettering Cancer CenterJanssen PharmaceuticalsRecruitingMultiple Myeloma | Monoclonal Gammopathy of Renal SignificanceUnited States
-
Memorial Sloan Kettering Cancer CenterPaula and Rodger Riney Foundation; Plantable; M and M labs; VeggieDoctor; Sabinsa...RecruitingMultiple Myeloma | Monoclonal Gammopathy of Undetermined SignificanceUnited States
-
Carevive Systems, Inc.CompletedMultiple MyelomaUnited States
-
CelgeneMultiple Myeloma Research ConsortiumCompleted
-
Biotest Pharmaceuticals CorporationBiotestCompletedMultiple MyelomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteCelgeneCompletedMyelomaUnited States
-
Divaya BhutaniGenzyme, a Sanofi CompanyRecruitingIsatuximab During Stem Cell Collection and Transplant in Patients With Multiple Myeloma and LymphomaLymphoma | Multiple Myeloma | Non-Hodgkin Lymphoma | Relapsed Hodgkin's Disease, AdultUnited States
-
NYU Langone HealthNational Cancer Institute (NCI)TerminatedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Thrombocytopenia | Refractory Multiple MyelomaUnited States
-
CelgeneCompleted
-
Massachusetts General HospitalMemorial Sloan Kettering Cancer Center; Mayo Clinic; Dana-Farber Cancer Institute and other collaboratorsCompletedMultiple MyelomaUnited States
-
Bellicum PharmaceuticalsSuspendedHER2-positive Breast Cancer | HER2-positive Gastric Cancer | Solid Tumor, Adult | HER-2 Gene Amplification | HER-2 Protein OverexpressionUnited States